China diagnostic reagent industry production & marketing and investment forecast report, 2013 2017

1. 2011 版
紧固件制造行业
China Diagnostic Reagent Industry Production & Marketing and
Investment Forecast Report, 2013-2017
There is no return to speak of when the decision is made without a full forecasting of the
industry situation
(Assists you in finding the gap in market needs of diagnostic reagent industry and defining the industry
development trend and investment prospects)
前 瞻 服 务 热 线 ： 800-8306390
service@qianzhan com
800-8306395
400-0687188
传 真 ： 0755-82940718

2. Diagnostic Reagent Industry
Foreword
Diagnostic reagent industry is a very vital part of biopharmaceutical industry. As to the current
domestic situation, China diagnostic industry is still in a weak growth period, as well as at a
preliminary stage of R&D and production investment, thus its mature growth period has not come yet.
China diagnostic market size is less than 1/10 of the global market share. Generally speaking, it's
widely used in clinic application (such as: hepatitis, sexually transmitted diseases in immunological
reagents, and pregnancy test series, as well as enzymes, lipid, liver function, blood sugar, urine test
and so on in clinical chemistry), besides, technological level in major domestic manufacturers has
reached that of in international manufacturers for the same period; the level of PCR technology in
genetic testing has reached the international of advanced level. Today, gene chip, cancer series is
catching up with the international level. Due to marketing and political factors, as well as the
backward mechatronics technology and so on, the development of projects in microbiology and
others show a slow progress, and their technological level is still relatively low.
Although the development of diagnostic reagent industry is still in its infancy, its high rate of return
continues to attract many investors. The diagnostic regent has a very high rate return. To be specific,
a new kind of diagnostic regent is generally able to recover the investment after 2 to 3 years listing,
especially for those companies with new and patented products. Once they develop a new kind of
product, technical monopoly will be formed and they can get more than 10 times rate of return. What
we should concern most is, large quantity of diagnostic reagent products are prone to make profits,
while small amount of products tend to be loss products. However, small amount products are
indispensable and it can also generate social benefits, which due to its small dosage. Meanwhile, the
economic benefits of new diagnostic reagents are better than that of traditional diagnostic reagents.
What's more, due to new diagnostic reagents with higher technical requirements and barriers, it's
difficult for other industries to enter this market and its products have higher value-added.
After about 20 years full competition, there are less manufactures in diagnostic reagent industry, and
the market concentration of its main products is high. In reality, a batch of scientific enterprises with
R&D capability grow rapidly and occupy most of the market.
Today, the global diagnostic reagent industry has a market size of over 30 billion US dollars, and
maintains an annual growth rate of around 5%. China diagnostic industry started to develop so late
and its development is unbalanced, but it still has a wide and bright development prospect. From the
view of medicine clinical practice in developed countries, diagnosis costs take up 20% to 30% of the
whole medical expenses, while in China, they just take up less than 10%. Therefore, there is a huge
market space not yet to developed. It's predicted that China diagnostic reagent market still has 15%
to 20% more growth rate to develop.
With the deepening of China's health care reform, the constantly improvement of the new rural
cooperative health care system, and the development of policies related to the industry, China
diagnostic reagent market will be further enlarged.
1

3. Diagnostic Reagent Industry
Along with the scale expansion of diagnostic reagent industry and the growing competition in the
industry, more and more diagnostic reagent manufacturing enterprises pay attention to the industry
market research, especially indepth researches on the industry development environment and product
buyers. Because of this, a large number of excellent diagnostic reagent brands rise up rapidly, and
gradually become leading corporations in China, or even in the global diagnostic reagent industry!
With Forward's long-term tracking and collecting market data of diagnostic reagent industry, we
roundly and accurately analyze the industry structure system for you from the view of mastering the
whole industry. This report mainly focuses on analyzing China diagnostic reagent industry's market
size, development speed and landscape trends, depending on macro prosperity of current diagnostic
reagent manufacturing industry and relying on its demand trend.
The report pay more attention to analyze the production and development of China diagnostic reagent
industry, current market environment of diagnostic reagent industry; import and export market of
diagnostic reagent industry; competitive landscape and trend of diagnostic reagent industry; market
segmentation analysis of diagnostic reagent industry; leading corporation operational condition in
diagnostic reagent industry, as well as development prospect of diagnostic reagent industry.
Meanwhile, with comprehensive and specific first-hand market data in 5 years. Forward helps you to
grasp the market and development trends of diagnostic reagent industry, so as to win advantages from
competition!
The most distinctive characteristics of this report is forward-looking and timeliness. Through
analyzing forward-looking characteristic of abundant first-hand market data, we deeply and
objectively dissect China diagnostic reagent industry’s market capacity, market size, competitive
landscape and characteristics of market demand. Furthermore, we conduct prudent analysis and
forecast for diagnostic reagent industry's future development trend. This report helps diagnostic
reagent manufacturing enterprises, R&D institutions, marketing enterprises and investment
enterprises to precisely grasp current latest developments of the industry. Afterwards, they can make
wise operating decisions and define enterprises' development directions.
Here, we would like to express our sincere gratitude to State Information Center, Bureau of Statistics
of China, China Customs, International Information Research Institute, Chinese Academy of
International Trade and Economic Cooperation, Tsinghua University Library, Development Research
Center of the State Council and Beijing Essence Forward Research Center, for their great support
when we conduct this report!
Notice: All the market data, especially corporations' ranking data in the report, only for business
reference. Please do not take the data for enterprise publicity. Thank you! Or Forward shall not take
any responsibility for any consequences!
Forward and Intelligence Co., Ltd. Industry Research Center
Research Team of Diagnostic Reagent Industry
2

4. Diagnostic Reagent Industry
CONTENTS
Chapter 1: Development Overview of Diagnostic Reagent Industry
1.1 Definition and Classification of Diagnostic Reagent
1.1.1 Definition of Diagnostic Reagent
1.1.2 Classification of Diagnostic Reagent
1.2 Statistical Standards of Diagnostic Reagent Industry
1.2.1 Statistical Departments and Coverage of Diagnostic Reagent Industry
1.2.2 Statistical Methods of Diagnostic Reagent Industry
1.2.3 Data Categories of Diagnostic Reagent Industry
1.3 Features Analysis of Diagnostic Reagent Industry
1.3.1 High Technology
1.3.2 High Investment
1.3.3 High Growth
1.3.4 High Profit
1.3.5 High Risk
1.4 Analysis of Upstream/Downstream Industries Supply Chain of Diagnostic Reagent Industry
1.4.1 Profile of Upstream/Downstream Industries Supply Chain of Diagnostic Reagent Industry
1.4.2 Analysis of Downstream Industrial Chain of Diagnostic Reagent Industry
(1) Medical Institutions Industry
(2) Independent Clinical Laboratory
(3) Blood Screening Market
(4) Food Testing Market
1.4.3 Analysis of Upstream Industry Supply Chain of Diagnostic Reagent Industry
(1) Medical Chemical Raw Materials Industry
(2) Medical Packaging Industry
Chapter 2: Analysis of Development of China Diagnostic Reagent Industry
2.1 Analysis of Development of China Diagnostic Reagent Industry
2.1.1 Overall Development Information of China Diagnostic Reagent Industry
2.1.2 Main Development Features of China Diagnostic Reagent Industry
2.1.3 Analysis of Operation of China Diagnostic Reagent Industry
(1) Analysis of Operational Benefit of China Diagnostic Reagent Industry
(2) Analysis of Profitability of China Diagnostic Reagent Industry
(3) Analysis of Operational Capability of China Diagnostic Reagent Industry
(4) Analysis of Debt-paying Ability of China Diagnostic Reagent Industry
3

5. Diagnostic Reagent Industry
(5) Analysis of Development Capability of Diagnostic Reagent Industry
2.2 Analysis of Economic Indexes of China Diagnostic Reagent Industry
2.2.1 Main Economic Benefit Influencing Factors to Diagnostic Reagent Industry
2.2.2 Analysis of Economic Indexes of China Diagnostic Reagent Industry
2.2.3 Analysis of Economic Indexes of Enterprises with Different Sizes
2.2.4 Analysis of Economic Indexes of Enterprises with Different Economic Properties
2.2.5 Analysis of Economic Indexes of Enterprises in Different Regions
2.3 Analysis of Balance between Supply and Demand of China Diagnostic Reagent Industry
2.3.1 Analysis of Supply of China Diagnostic Reagent Industry
(1) Analysis of Total Industrial Output Value of National Special Cable Industry
(2) Analysis of Finished Products of National Special Cable Industry
2.3.2 Analysis of Supply of Regional Diagnostic Reagent Industry
(1) Analysis of Top 10 Regions with Highest Total Industrial Output Value
(2) Analysis of Top Regions with Most Finished Products
2.3.3 Analysis of Demand of China Diagnostic Reagent Industry
(1) Analysis of Sales Value of China Diagnostic Reagent Industry
(2) Analysis of Sales Revenue of China Diagnostic Reagent Industry
2.3.4 Analysis of Demand Situation of Regional Diagnostic Reagent Industry
(1) Analysis of Top 10 Regions with Highest Sales Value
(2) Analysis of Top Regions with Highest Sales Revenue
2.3.5 Analysis of Production and Marketing Rate of China Diagnostic Reagent Industry
2.4 Analysis of Operation of China Diagnostic Reagent Industry
2.4.1 Analysis of Industry Size of China Diagnostic Reagent Industry
2.4.2 Analysis of Asset/Labor Intensity of China Diagnostic Reagent Industry
2.4.3 Analysis of Production and Marketing of China Diagnostic Reagent Industry
2.4.4 Analysis of Profits and Loss of China Diagnostic Reagent Industry
Chapter 3: Analysis of Market Environment of China Diagnostic Reagent Industry
3.1 Analysis of Industry Policy Environment
3.1.1 Industry Supervision System
3.1.2 Policies Related to Industry
(1) Opinions on Deepening the Reform of the Health Care System
(2) Detailed Rules of Policies on Promoting Development of Bio-industry
(3) Developing Strategic Emerging Industries and “Twelfth Five-year” Plan for Bio-Medical
Sector
(4) Registration Management Measures for In Vitro Diagnostics
4

6. Diagnostic Reagent Industry
3.1.3 Industry Development Planning
3.2 Analysis of Industry Economic Environment
3.2.1 China GDP Growth
3.2.2 GDP Per Capital Growth
3.2.3 Resident Income Growth
3.2.4 Expense Level of Resident Consumption
3.2.5 Analysis of Resident Consumption Structure
3.3 Analysis of Industry Demand Environment
3.3.1 Population Scale
3.3.2 Population Structure Changes
3.3.3 Resident Illness
3.3.4 Healthcare Level of Residents
3.3.5 China’s Infectious Disease
3.4 Analysis of Industry Product Technology Environment
3.4.1 Technological Level of International Diagnostic Reagent Industry
3.4.2 Technological Level of China Diagnostic Reagent Industry
3.4.3 Latest Progress of China Diagnostic Reagent Industry
Chapter 4: Analysis of Market Competition of Diagnostic Reagent Industry
4.1 Analysis of competition of Global Diagnostic Reagent Industry
4.1.1 Development of Global Diagnostic Reagent Market
4.1.2 Competitive Landscape of Global Diagnostic Reagent Industry
4.1.3 Development Prospects for Global Diagnostic Reagent Industry
4.2 Analysis of Competition of China Diagnostic Reagent Industry
4.2.1 Analysis of Market Size of China Diagnostic Reagent Industry
4.2.2 Concentration Analysis of China Diagnostic Reagent Industry
(1) Concentration Analysis of Industry Sales
(2) Concentration Analysis of Industry Assets
4.2.3 Competitive Landscape of China Diagnostic Reagent Industry
4.2.4 Analysis of Bargaining Power of Diagnostic Reagent Industry
4.2.5 Analysis of Potential Threats of Domestic Diagnostic Reagent Industry
4.2.6 Product Competitive Strategies for Diagnostic Reagent Manufacturing Enterprises
4.3 Regional Market Features of Diagnostic Reagent Industry
4.3.1 Overall Features of Industry Regional Structure
4.3.2 Analysis of Industry Regional Concentration
5

7. Diagnostic Reagent Industry
4.3.3 Analysis of Enterprises with Different Economic Properties in Industry
(1) Features of Enterprises with Different Economic Properties
(2) Concentration Analysis of Industry Economic Properties
Chapter 5: Analysis of Main Products in Diagnostic Reagent Industry
5.1 Features of Industry Main Product Structures
5.2 Analysis of Industry Main Products Market
5.2.1 Analysis of Biochemical Diagnostic Reagent Market
5.2.2 Analysis of Immuno Diagnostic Reagent Market
5.2.3 Analysis of Nucleic Acid Diagnostic Reagent Market
5.2.4 Analysis of Microbial Diagnostic Reagent Market
5.2.5 Analysis of Diagnostic Instrument Market
5.3 Analysis of Hot Market Segments of Diagnostic Reagent Industry
5.3.1 Analysis of Cardiovascular Diagnostic Reagent Market
(1) China Cardiovascular Disease
(2) Demand Status of Cardiovascular Diagnostic Reagent
(3) Application of Cardiovascular Diagnostic Reagent
(4) Market Development Prospects for Cardiovascular Diagnostic Reagent
5.3.2 Analysis of Hepatitis Diagnostic Reagent Market
(1) China Hepatitis Disease
(2) Demand Status of Hepatitis Diagnostic Reagent
(3) Research Progress of Hepatitis Diagnostic Reagent
(4) Market Development Prospects for Hepatitis Diagnostic Reagent
5.3.3 Analysis of Tumor Marker Detective Reagent Market
(1) China Tumor Disease
(2) Demand Status of Tumor Marker Detective Reagent Market
(3) Application of Tumor Marker Detective Reagent Market
(4) Market Demand Prospects for Tumor Marker Detective Reagent
5.3.4 Analysis of Prenatal and Postnatal Care Diagnostic Reagent Market
(1) China’s Total Population and Population Structure
(2) Demand Status of Prenatal and Postnatal Care Diagnostic Reagent
(3) Application of Prenatal and Postnatal Care Diagnostic Reagent
(4) Market Demand Prospects for Prenatal and Postnatal Care Diagnostic Reagent
5.3.5 Analysis of Venereal Disease Diagnostic Reagent Market
(1) China Venereal Disease
6

8. Diagnostic Reagent Industry
(2) Demand Status of Venereal Disease Diagnostic Reagent Market
(3) Application of Venereal Disease Diagnostic Reagent Market
(4) Market Development Prospects for Venereal Disease Diagnostic Reagent
Chapter 6: Analysis of Import and Export of China Diagnostic Reagent Industry
6.1 Overall Import and Export of Diagnostic Reagent Industry
6.2 Analysis of Export Market of Diagnostic Reagent Industry
6.2.1 Analysis of Industry Export
(1) Overall Information of Industry Export
(2) Product Structure of Industry Export
6.2.2 Analysis of Industry Export
(1) Overall Information of Industry Export
(2) Product Structure of Industry Export
6.3 Analysis of Import Market of Diagnostic Reagent Industry
6.3.1 Analysis of Industry Import
(1) Overall Information of Industry Import
(2) Product Structure of Industry Import
6.3.2 Analysis of Industry Import
(1) Overall Information of Industry Import
(2) Product Structure of Industry Import
6.4 Import and Export Prospects and Suggestions for Diagnostic Reagent Industry
6.4.1 Export Prospects and Suggestions for Diagnostic Reagent Industry
6.4.2 Import Prospects and Suggestions for Diagnostic Reagent Industry
Chapter 7: Analysis of Leading Enterprises in Diagnostic Reagent Industry
7.1 Roche Group
7.1.1 Analysis of Enterprise Development Profile
7.1.2 Analysis of Enterprise Operation
7.1.3 Analysis of Enterprise Main Products
7.1.4 Enterprise Investment Layout in China
7.1.5 Enterprise Latest Development Trend
7.2 Johnson & Johnson
7.2.1 Analysis of Enterprise Development Profile
7.2.2 Analysis of Enterprise Operation
7.2.3 Analysis of Enterprise Main Products
7.2.4 Enterprise Investment Layout in China
7

9. Diagnostic Reagent Industry
7.2.5 Enterprise Latest Development Trend
7.3 Pfizer Inc.
7.3.1 Analysis of Enterprise Development Profile
7.3.2 Analysis of Enterprise Operation
7.3.3 Analysis of Enterprise Main Products
7.3.4 Enterprise Investment Layout in China
7.3.5 Enterprise Latest Development Trend
7.4 Abbott Laboratories
7.4.1 Analysis of Enterprise Development Profile
7.4.2 Analysis of Enterprise Operation
7.4.3 Analysis of Enterprise Main Products
7.4.4 Enterprise Investment Layout in China
7.4.5 Enterprise Latest Development Trend
7.5 Siemens Healthcare
7.5.1 Analysis of Enterprise Development Profile
7.5.2 Analysis of Enterprise Operation
7.5.3 Analysis of Enterprise Main Products
7.5.4 Enterprise Investment Layout in China
7.5.5 Enterprise Latest Development Trend
(1) Analysis of Leading Enterprises in Domestic Diagnostic Reagent Industry
7.6 Operation Analysis of Shanghai Kehua Bio-Engineering Co., Ltd.
7.6.1 Analysis of Enterprise Development Profile
7.6.2 Analysis of Main Economic Indexes
7.6.3 Analysis of Enterprise Profitability
7.6.4 Analysis of Enterprise Operational Capability
7.6.5 Analysis of Enterprise Debt-paying Ability
7.6.6 Analysis of Enterprise Development Capability
7.6.7 Enterprise Product Structure and New Product Trend
7.6.8 Enterprise Marketing Channels and Networks
7.6.9 SWOT Analysis of Enterprise Operation
7.6.10 Analysis of Enterprise Investment, Merger and Restructuring
7.6.11 Analysis of Enterprise Latest Development Trend
7.7 Operation Analysis of Da An Gene Co.，Ltd. of Sun Yat-Sen University
7.7.1 Analysis of Enterprise Development Profile
7.7.2 Analysis of Main Economic Indexes
8

10. Diagnostic Reagent Industry
7.7.3 Analysis of Enterprise Profitability
7.7.4 Analysis of Enterprise Operational Capability
7.7.5 Analysis of Enterprise Debt-paying Ability
7.7.6 Analysis of Enterprise Development Capability
7.7.7 Enterprise Product Structure and New Product Trend
7.7.8 Enterprise Marketing Channels and Networks
7.7.9 SWOT Analysis of Enterprise Operation
7.7.10 Analysis of Enterprise Investment, Merger and Restructuring
7.7.11 Analysis of Enterprise Latest Development Trend
7.8 Operation Analysis of Beijing Wantai Biological Pharmacy Co., Ltd.
7.8.1 Analysis of Enterprise Development Profile
7.8.2 Analysis of Enterprise Production and Marketing Capability
7.8.3 Analysis of Enterprise Profitability
7.8.4 Analysis of Enterprise Operational Capability
7.8.5 Analysis of Enterprise Debt-paying Ability
7.8.6 Analysis of Enterprise Development Capability
7.8.7 Enterprise Product Structure and New Product Trend
7.8.8 Enterprise Marketing Channels and Networks
7.8.9 SWOT Analysis of Enterprise Operation
7.8.10 Analysis of Enterprise Latest Development Trend
7.9 Operation Analysis of Dirui Industrial Co., Ltd.
7.9.1 Analysis of Enterprise Development Profile
7.9.2 Analysis of Enterprise Production and Marketing Capability
7.9.3 Analysis of Enterprise Profitability
7.9.4 Analysis of Enterprise Operational Capability
7.9.5 Analysis of Enterprise Debt-paying Ability
7.9.6 Analysis of Enterprise Development Capability
7.9.7 Enterprise Product Structure and New Product Trend
7.9.8 Enterprise Marketing Channels and Networks
7.9.9 SWOT Analysis of Enterprise Operation
7.10 Operation Analysis of Biosino Bio-technology and Science Inc.
7.10.1 Analysis of Enterprise Development Profile
7.10.2 Analysis of Main Economic Indexes
7.10.3 Analysis of Enterprise Profitability
7.10.4 Analysis of Enterprise Operational Capability
9

11. Diagnostic Reagent Industry
7.10.5 Analysis of Enterprise Debt-paying Ability
7.10.6 Analysis of Enterprise Development Capability
7.10.7 Enterprise Product Structure and New Product Trend
7.10.8 Enterprise Marketing Channels and Networks
7.10.9 SWOT Analysis of Enterprise Operation
7.10.10 Analysis of Enterprise Investment, Merger and Restructuring
7.10.11 Analysis of Enterprise Latest Development Trend
7.11 Operation Analysis of Yingke Xinchuang (Xiamen) Technology Co., Ltd.
7.11.1 Analysis of Enterprise Development Profile
7.11.2 Analysis of Enterprise Production and Marketing Capability
7.11.3 Analysis of Enterprise Profitability
7.11.4 Analysis of Enterprise Operational Capability
7.11.5 Analysis of Enterprise Debt-paying Ability
7.11.6 Analysis of Enterprise Development Capability
7.11.7 Enterprise Product Structure and New Product Trend
7.11.8 Enterprise Marketing Channels and Networks
7.11.9 SWOT Analysis of Enterprise Operation
7.11.10 Analysis of Enterprise Latest Development Trend
7.12 Operation Analysis of Zhu Hai Livzon Diagnostics Inc.
7.12.1 Analysis of Enterprise Development Profile
7.12.2 Analysis of Enterprise Production and Marketing Capability
7.12.3 Analysis of Enterprise Profitability
7.12.4 Analysis of Enterprise Operational Capability
7.12.5 Analysis of Enterprise Debt-paying Ability
7.12.6 Analysis of Enterprise Development Capability
7.12.7 Enterprise Product Structure and New Product Trend
7.12.8 Enterprise Marketing Channels and Networks
7.12.9 SWOT Analysis of Enterprise Operation
7.12.10 Analysis of Enterprise Latest Development Trend
7.13 Operation Analysis of Guangzhou Wondofo Biomedical Co., Ltd.
7.13.1 Analysis of Enterprise Development Profile
7.13.2 Analysis of Enterprise Production and Marketing Capability
7.13.3 Analysis of Enterprise Profitability
7.13.4 Analysis of Enterprise Operational Capability
7.13.5 Analysis of Enterprise Debt-paying Ability
10

12. Diagnostic Reagent Industry
7.13.6 Analysis of Enterprise Development Capability
7.13.7 Enterprise Product Structure and New Product Trend
7.13.8 Enterprise Marketing Channels and Networks
7.13.9 SWOT Analysis of Enterprise Operation
7.13.10 Analysis of Enterprise Latest Development Trend
7.14 Operation Analysis of Shanghai Fosun Long March Medical Science Co., Ltd.
7.14.1 Analysis of Enterprise Development Profile
7.14.2 Analysis of Enterprise Production and Marketing Capability
7.14.3 Analysis of Enterprise Profitability
7.14.4 Analysis of Enterprise Operational Capability
7.14.5 Analysis of Enterprise Debt-paying Ability
7.14.6 Analysis of Enterprise Development Capability
7.14.7 Enterprise Product Structure and New Product Trend
7.14.8 Enterprise Marketing Channels and Networks
7.14.9 SWOT Analysis of Enterprise Operation
7.15 Operation Analysis of Yantai Ausbio Laboratories Co., Ltd.
7.15.1 Analysis of Enterprise Development Profile
7.15.2 Analysis of Enterprise Production and Marketing Capability
7.15.3 Analysis of Enterprise Profitability
7.15.4 Analysis of Enterprise Operational Capability
7.15.5 Analysis of Enterprise Debt-paying Ability
7.15.6 Analysis of Enterprise Development Capability
7.15.7 Enterprise Product Structure and New Product Trend
7.15.8 Enterprise Marketing Channels and Networks
7.15.9 SWOT Analysis of Enterprise Operation
7.16 Operation Analysis of Acon Biotech（Hangzhou）Co., Ltd.
7.16.1 Analysis of Enterprise Development Profile
7.16.2 Analysis of Enterprise Production and Marketing Capability
7.16.3 Analysis of Enterprise Profitability
7.16.4 Analysis of Enterprise Operational Capability
7.16.5 Analysis of Enterprise Debt-paying Ability
7.16.6 Analysis of Enterprise Development Capability
7.16.7 Enterprise Product Structure and New Product Trend
7.16.8 Enterprise Marketing Channels and Networks
7.16.9 SWOT Analysis of Enterprise Operation
11

13. Diagnostic Reagent Industry
7.16.10 Analysis of Enterprise Latest Development Trend
7.17 Operation Analysis of Huasin Science Co., Ltd.
7.17.1 Analysis of Enterprise Development Profile
7.17.2 Analysis of Enterprise Production and Marketing Capability
7.17.3 Analysis of Enterprise Profitability
7.17.4 Analysis of Enterprise Operational Capability
7.17.5 Analysis of Enterprise Debt-paying Ability
7.17.6 Analysis of Enterprise Development Capability
7.17.7 Enterprise Product Structure and New Product Trend
7.17.8 Enterprise Marketing Channels and Networks
7.17.9 SWOT Analysis of Enterprise Operation
7.17.10 Analysis of Enterprise Latest Development Trend
7.18 Operation Analysis of Beijing Leadman Biochemistry Co., Ltd.
7.18.1 Analysis of Enterprise Development Profile
7.18.2 Analysis of Enterprise Production and Marketing Capability
7.18.3 Analysis of Enterprise Profitability
7.18.4 Analysis of Enterprise Operational Capability
7.18.5 Analysis of Enterprise Debt-paying Ability
7.18.6 Analysis of Enterprise Development Capability
7.18.7 Enterprise Product Structure and New Product Trend
7.18.8 Enterprise Marketing Channels and Networks
7.18.9 SWOT Analysis of Enterprise Operation
7.18.10 Analysis of Enterprise Latest Development Trend
7.19 Operation Analysis of Nanchang Biotech A&C Biotechnical Industry Incorporated Company
7.19.1 Analysis of Enterprise Development Profile
7.19.2 Analysis of Main Economic Indexes
7.19.3 Analysis of Enterprise Profitability
7.19.4 Analysis of Enterprise Operational Capability
7.19.5 Analysis of Enterprise Debt-paying Ability
7.19.6 Analysis of Enterprise Development Capability
7.19.7 Enterprise Product Structure and New Product Trend
7.19.8 Enterprise Marketing Channels and Networks
7.19.9 SWOT Analysis of Enterprise Operation
7.19.10 Analysis of Enterprise Investment, Merger and Restructuring
7.19.11 Analysis of Enterprise Latest Development Trend
12

14. Diagnostic Reagent Industry
7.20 Operation Analysis of Autobio Diagnostics Co., Ltd.
7.20.1 Analysis of Enterprise Development Profile
7.20.2 Analysis of Enterprise Production and Marketing Capability
7.20.3 Analysis of Enterprise Profitability
7.20.4 Analysis of Enterprise Operational Capability
7.20.5 Analysis of Enterprise Debt-paying Ability
7.20.6 Analysis of Enterprise Development Capability
7.20.7 Enterprise Product Structure and New Product Trend
7.20.8 Enterprise Marketing Channels and Networks
7.20.9 SWOT Analysis of Enterprise Operation
7.20.10 Analysis of Enterprise Latest Development Trend
7.21 Operation Analysis of Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
7.21.1 Analysis of Enterprise Development Profile
7.21.2 Analysis of Main Economic Indexes
7.21.3 Analysis of Enterprise Profitability
7.21.4 Analysis of Enterprise Operational Capability
7.21.5 Analysis of Enterprise Debt-paying Ability
7.21.6 Analysis of Enterprise Development Capability
7.21.7 Enterprise Product Structure and New Product Trend
7.21.8 Enterprise Marketing Channels and Networks
7.21.9 SWOT Analysis of Enterprise Operation
7.21.10 Analysis of Enterprise Investment, Merger and Restructuring
7.21.11 Analysis of Enterprise Latest Development Trend
7.22 Operation Analysis of Guilin Urit Electronic Sales Co., Ltd.
7.22.1 Analysis of Enterprise Development Profile
7.22.2 Analysis of Enterprise Production and Marketing Capability
7.22.3 Analysis of Enterprise Profitability
7.22.4 Analysis of Enterprise Operational Capability
7.22.5 Analysis of Enterprise Debt-paying Ability
7.22.6 Analysis of Enterprise Development Capability
7.22.7 Enterprise Product Structure and New Product Trend
7.22.8 Enterprise Marketing Channels and Networks
7.22.9 SWOT Analysis of Enterprise Operation
7.22.10 Analysis of Enterprise Latest Development Trend
7.23 Operation Analysis of Chengdu Yongan Pharmaceutical Co., Ltd.
13

15. Diagnostic Reagent Industry
7.23.1 Analysis of Enterprise Development Profile
7.23.2 Analysis of Enterprise Production and Marketing Capability
7.23.3 Analysis of Enterprise Profitability
7.23.4 Analysis of Enterprise Operational Capability
7.23.5 Analysis of Enterprise Debt-paying Ability
7.23.6 Analysis of Enterprise Development Capability
7.23.7 Enterprise Product Structure and New Product Trend
7.23.8 Enterprise Marketing Channels and Networks
7.23.9 SWOT Analysis of Enterprise Operation
7.23.10 Analysis of Enterprise Latest Development Trend
7.24 Operation Analysis of Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
7.24.1 Analysis of Enterprise Development Profile
7.24.2 Analysis of Enterprise Production and Marketing Capability
7.24.3 Analysis of Enterprise Profitability
7.24.4 Analysis of Enterprise Operational Capability
7.24.5 Analysis of Enterprise Debt-paying Ability
7.24.6 Analysis of Enterprise Development Capability
7.24.7 Enterprise Product Structure and New Product Trend
7.24.8 Enterprise Marketing Channels and Networks
7.24.9 SWOT Analysis of Enterprise Operation
7.24.10 Analysis of Enterprise Latest Development Trend
7.25 Operation Analysis of Zhejiang Elikan Biological Technology Co., Ltd.
7.25.1 Analysis of Enterprise Development Profile
7.25.2 Analysis of Enterprise Production and Marketing Capability
7.25.3 Analysis of Enterprise Profitability
7.25.4 Analysis of Enterprise Operational Capability
7.25.5 Analysis of Enterprise Debt-paying Ability
7.25.6 Analysis of Enterprise Development Capability
7.25.7 Enterprise Product Structure and New Product Trend
7.25.8 Enterprise Marketing Channels and Networks
7.25.9 SWOT Analysis of Enterprise Operation
7.25.10 Analysis of Enterprise Latest Development Trend
7.26 Operation Analysis of ABON Biopharm (Hangzhou) Co., Ltd.
7.26.1 Analysis of Enterprise Development Profile
7.26.2 Analysis of Enterprise Production and Marketing Capability
14

16. Diagnostic Reagent Industry
7.26.3 Analysis of Enterprise Profitability
7.26.4 Analysis of Enterprise Operational Capability
7.26.5 Analysis of Enterprise Debt-paying Ability
7.26.6 Analysis of Enterprise Development Capability
7.26.7 Enterprise Product Structure and New Product Trend
7.26.8 Enterprise Marketing Channels and Networks
7.26.9 SWOT Analysis of Enterprise Operation
7.26.10 Analysis of Enterprise Latest Development Trend
7.27 Operation Analysis of Beijing Strong Biotechnologies Inc.
7.27.1 Analysis of Enterprise Development Profile
7.27.2 Analysis of Enterprise Production and Marketing Capability
7.27.3 Analysis of Enterprise Profitability
7.27.4 Analysis of Enterprise Operational Capability
7.27.5 Analysis of Enterprise Debt-paying Ability
7.27.6 Analysis of Enterprise Development Capability
7.27.7 Enterprise Product Structure and New Product Trend
7.27.8 Enterprise Marketing Channels and Networks
7.27.9 SWOT Analysis of Enterprise Operation
7.27.10 Analysis of Enterprise Latest Development Trend
7.28 Operation Analysis of Chengdu Institute of Biological Products
7.28.1 Analysis of Enterprise Development Profile
7.28.2 Analysis of Enterprise Production and Marketing Capability
7.28.3 Analysis of Enterprise Profitability
7.28.4 Analysis of Enterprise Operational Capability
7.28.5 Analysis of Enterprise Debt-paying Ability
7.28.6 Analysis of Enterprise Development Capability
7.28.7 Enterprise Product Structure and New Product Trend
7.28.8 Enterprise Marketing Channels and Networks
7.28.9 SWOT Analysis of Enterprise Operation
7.28.10 Analysis of Enterprise Latest Development Trend
7.29 Operation Analysis of Caje Biopharmaceutical (Shenzhen) Co., Ltd.
7.29.1 Analysis of Enterprise Development Profile
7.29.2 Analysis of Enterprise Production and Marketing Capability
7.29.3 Analysis of Enterprise Profitability
7.29.4 Analysis of Enterprise Operational Capability
15

17. Diagnostic Reagent Industry
7.29.5 Analysis of Enterprise Debt-paying Ability
7.29.6 Analysis of Enterprise Development Capability
7.29.7 Enterprise Product Structure and New Product Trend
7.29.8 Enterprise Marketing Channels and Networks
7.29.9 SWOT Analysis of Enterprise Operation
7.29.10 Analysis of Enterprise Latest Development Trend
7.30 Operation Analysis of Beijing Ascle Bioengineering Company
7.30.1 Analysis of Enterprise Development Profile
7.30.2 Analysis of Enterprise Operation
7.30.3 Enterprise Product Structure and New Product Trend
7.30.4 Enterprise Marketing Channels and Networks
7.30.5 SWOT Analysis of Enterprise Operation
7.30.6 Analysis of Enterprise Latest Development Trend
Chapter 8: Development Trend and Forecast for China Diagnostic Reagent Industry
8.1 Development Trend of China Diagnostic Reagent Industry
8.1.1 Development Trend of China Diagnostic Reagent Market
(1) Demand Trend
(2) Product Trend
(3) Technology Trend
8.2 Analysis of Investment Features of Diagnostic Reagent Industry
8.2.1 Analysis of Entry Barriers of Diagnostic Reagent Industry
8.2.2 Analysis of Profit Modes of Diagnostic Reagent Industry
8.2.3 Analysis of Profit Factors of Diagnostic Reagent Industry
8.3 Investment Risks of China Diagnostic Reagent Industry
8.3.1 Policy Risks of Diagnostic Reagent Industry
8.3.2 Technology Risks of Diagnostic Reagent Industry
8.3.3 Supply and Demand Risks of Diagnostic Reagent Industry
8.3.4 Macro-economic Fluctuation Risks of Diagnostic Reagent Industry
8.3.5 Relevant Industries Risks of Diagnostic Reagent Industry
8.3.6 Product Structure Risks of Diagnostic Reagent Industry
8.3.7 Risks of Enterprise Production Scale and Ownership
8.3.8 Other Risks of Diagnostic Reagent Industry
8.4 Investment Suggestions for China Diagnostic Reagent Industry
8.4.1 Analysis of Investment Status of Diagnostic Reagent Industry
8.4.2 Main Investment Suggestions for Diagnostic Reagent Industry
16

18. Diagnostic Reagent Industry
By Qianzhan Intelligence
Website: http://en.qianzhan.com/
Tel:+86 0755 33220413
Email us: carter@qianzhan.com.cn
17